| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
|
Science
|
2006
|
27.49
|
|
2
|
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.
|
Nat Genet
|
2007
|
19.08
|
|
3
|
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.
|
Nat Genet
|
2010
|
17.38
|
|
4
|
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
|
Nature
|
2012
|
16.13
|
|
5
|
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
|
Am J Gastroenterol
|
2006
|
1.79
|
|
6
|
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis.
|
Gastroenterology
|
2007
|
1.64
|
|
7
|
Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission.
|
Inflamm Bowel Dis
|
2011
|
1.51
|
|
8
|
Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC).
|
Inflamm Bowel Dis
|
2007
|
1.26
|
|
9
|
Biologic therapy in the management of extraintestinal manifestations of inflammatory bowel disease.
|
Inflamm Bowel Dis
|
2007
|
1.20
|
|
10
|
Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center.
|
Inflamm Bowel Dis
|
2010
|
1.11
|
|
11
|
Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity.
|
Dig Dis Sci
|
2012
|
1.10
|
|
12
|
Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium.
|
Am J Gastroenterol
|
2012
|
1.02
|
|
13
|
Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.
|
Inflamm Bowel Dis
|
2013
|
0.97
|
|
14
|
Five-Year Period Prevalence and Characteristics of Anemia in a Large US Inflammatory Bowel Disease Cohort.
|
J Clin Gastroenterol
|
2016
|
0.96
|
|
15
|
Prevention and treatment of postoperative Crohn's disease recurrence: an update for a new decade.
|
Curr Gastroenterol Rep
|
2011
|
0.96
|
|
16
|
Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease.
|
Curr Treat Options Gastroenterol
|
2007
|
0.92
|
|
17
|
Systemic mastocytosis mimicking inflammatory bowel disease: A case report and discussion of gastrointestinal pathology in systemic mastocytosis.
|
Am J Surg Pathol
|
2006
|
0.90
|
|
18
|
Postoperative Crohn's disease: prevention and treatment.
|
Expert Rev Gastroenterol Hepatol
|
2009
|
0.86
|
|
19
|
Segmental colitis associated with diverticulosis.
|
Dig Dis Sci
|
2002
|
0.84
|
|
20
|
Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease-associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma.
|
Am J Surg Pathol
|
2014
|
0.84
|
|
21
|
Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials.
|
Inflamm Bowel Dis
|
2015
|
0.84
|
|
22
|
Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease.
|
Inflamm Bowel Dis
|
2015
|
0.84
|
|
23
|
Management of persistent gastric bleeding in a patient with Glanzmann's thrombasthenia.
|
Am J Hematol
|
2008
|
0.83
|
|
24
|
Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repository.
|
Am J Gastroenterol
|
2009
|
0.83
|
|
25
|
Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.
|
Inflamm Bowel Dis
|
2016
|
0.82
|
|
26
|
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent Hospitalization.
|
Inflamm Bowel Dis
|
2015
|
0.82
|
|
27
|
The Influence of Anti-tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease.
|
Inflamm Bowel Dis
|
2015
|
0.82
|
|
28
|
Radiologic testing in Crohn's disease.
|
Inflamm Bowel Dis
|
2008
|
0.80
|
|
29
|
Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis.
|
Dig Dis Sci
|
2012
|
0.80
|
|
30
|
Preventive therapy in postoperative Crohn's disease.
|
Curr Opin Gastroenterol
|
2010
|
0.79
|
|
31
|
Evaluation for postoperative recurrence of Crohn disease.
|
Gastroenterol Clin North Am
|
2012
|
0.79
|
|
32
|
Pathologic features of early inflammatory bowel disease.
|
Gastroenterol Clin North Am
|
2002
|
0.79
|
|
33
|
Delineation of Crohn's Disease Trajectories Using Change in Lémann Index: A Natural History Study.
|
J Clin Gastroenterol
|
2016
|
0.78
|
|
34
|
Postoperative management of Crohn disease.
|
Med Clin North Am
|
2010
|
0.78
|
|
35
|
Postoperative Crohn's disease: how can we prevent it?
|
Expert Rev Clin Immunol
|
2010
|
0.78
|
|
36
|
Postoperative management of crohn disease.
|
Gastroenterol Clin North Am
|
2009
|
0.78
|
|
37
|
Stopping, continuing, or restarting immunomodulators and biologics when an infection or malignancy develops.
|
Inflamm Bowel Dis
|
2014
|
0.77
|
|
38
|
Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement.
|
Inflamm Bowel Dis
|
2015
|
0.77
|
|
39
|
Quality of Sleep and Coexistent Psychopathology Have Significant Impact on Fatigue Burden in Patients With Inflammatory Bowel Disease.
|
J Clin Gastroenterol
|
2016
|
0.77
|
|
40
|
Clinical course of Crohn's disease following treatment of lymphoma.
|
Inflamm Bowel Dis
|
2011
|
0.76
|
|
41
|
The Cost of Crohn's Disease: Varied Health Care Expenditure Patterns Across Distinct Disease Trajectories.
|
Inflamm Bowel Dis
|
2016
|
0.75
|
|
42
|
A Pilot Study of the Prevalence of Anal Human Papillomavirus and Dysplasia in a Cohort of Patients With IBD.
|
Dis Colon Rectum
|
2017
|
0.75
|
|
43
|
Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study.
|
J Clin Gastroenterol
|
2017
|
0.75
|
|
44
|
Ultra-high C-reactive protein levels in hospitalized inflammatory bowel disease (IBD) patients predicts serious complications.
|
Int J Colorectal Dis
|
2013
|
0.75
|
|
45
|
An unusual cause of lower gastrointestinal bleeding in Crohn's disease. Malignant infiltration with Epstein-Barr virus-positive diffuse large B-cell non-Hodgkin's lymphoma.
|
Gastroenterology
|
2012
|
0.75
|
|
46
|
Management of perianal fistula in Crohn's disease.
|
Inflamm Bowel Dis
|
2008
|
0.75
|
|
47
|
Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis.
|
Inflamm Bowel Dis
|
2017
|
0.75
|
|
48
|
Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis.
|
Inflamm Bowel Dis
|
2016
|
0.75
|
|
49
|
Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active Inflammation.
|
Inflamm Bowel Dis
|
2016
|
0.75
|